Potential Reduction of Interstitial Myocardial Fibrosis With Renal Denervation

被引:39
作者
Doltra, Adelina [1 ]
Messroghli, Daniel [1 ,2 ]
Stawowy, Philipp [1 ]
Hassel, Jan-Hendrik [1 ]
Gebker, Rolf [1 ]
Leppaenen, Olli [3 ]
Graefe, Michael [1 ]
Schneeweis, Christopher [1 ]
Schnackenburg, Bernhard [4 ]
Fleck, Eckart [1 ]
Kelle, Sebastian [1 ,2 ]
机构
[1] Deutsch Herzzentrum Berlin, Dept Internal Med Cardiol, Berlin, Germany
[2] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany
[3] Uppsala Univ, Ctr Res & Dev, Cty Council Gavleborg, Gavle, Sweden
[4] Philips Healthcare Clin Sci, Hamburg, Germany
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2014年 / 3卷 / 06期
关键词
cardiac; cardiac magnetic resonance; extracellular volume fraction; interstitial myocardial fibrosis; renal denervation; CARDIOVASCULAR MAGNETIC-RESONANCE; LEFT-VENTRICULAR HYPERTROPHY; EXTRACELLULAR-MATRIX EXPANSION; RESISTANT HYPERTENSION; SYMPATHETIC DENERVATION; REGRESSION; PRESSURE; ASSOCIATION; PROGRESSION; COMMITTEE;
D O I
10.1161/JAHA.114.001353
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Hypertensive cardiomyopathy is characterized by myocyte hypertrophy and interstitial fibrosis. The effects of renal denervation (RD) on the heart are poorly understood. New magnetic resonance imaging techniques (extracellular volume fraction) permit the quantitative assessment of myocardial fibrosis. Our aim was to study the effects of RD on myocardial fibrosis. Methods and Results-Twenty-three patients with resistant hypertension undergoing RD and 5 resistant hypertensive controls were prospectively included. Cardiac magnetic resonance imaging at 1.5 T was performed before RD and at 6-month follow-up. Indexed left ventricular mass, septal extracellular volume fraction, and indexed absolute extracellular volume (a quantitative measure of extracellular matrix) were quantified. All data are reported as mean +/- SD deviation (median). Decreases in systolic (161.96 +/- 19.09 [160] versus 144.78 +/- 16.48 [143] mm Hg, P< 0.0001) and diastolic (85.61 +/- 12.88 [83] versus 80.39 +/- 11.93 [81] mm Hg, P= 0.018) blood pressures and in indexed left ventricular mass (41.83 +/- 10.20 [41.59] versus 37.72 +/- 7.44 [38.49] g/m1.7, P= 0.001) were observed at follow- up only in RD patients. No significant differences in extracellular volume were found (26.24 +/- 3.92% [26.06%] versus 25.74 +/- 4.53% [25.63%], P= 0.605). A significant decrease in absolute extracellular volume was observed after 6 months in RD patients exclusively (10.36 +/- 2.25 [10.79] versus 9.25 +/- 2.38 [9.79] mL/m1.7, P= 0.031). This effect was observed independently of blood pressure reduction. Conclusions-RD significantly decreases left ventricular mass, while extracellular volume remains stable. Our results suggest that the observed left ventricular mass decrease was due not exclusively to a reversion of myocyte hypertrophy but also to an additional reduction in collagen content, indicating interstitial myocardial fibrosis.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Resistant hypertension: Multivariate predictors of blood pressure response to renal denervation
    Prochnau, Dirk
    Heymel, Stefan
    Goebel, Bjoern
    Figulla, Hans R.
    Surber, Ralf
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 3130 - 3132
  • [42] Renal denervation in patients with resistant hypertension: Six-month results
    Dores, Helder
    Almeida, Manuel de Sousa
    Goncalves, Pedro de Araujo
    Branco, Patricia
    Gaspar, Augusta
    Sousa, Henrique
    Gomes, Angela Canha
    Andrade, Maria Joao
    Carvalho, Maria Salome
    Teles, Rui Campante
    Raposo, Luis
    Gabriel, Henrique Mesquita
    Machado, Francisco Pereira
    Mendes, Miguel
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2014, 33 (04) : 197 - 204
  • [43] Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis
    Bing, Rong
    Cavalcante, Joao L.
    Everett, Russell J.
    Clavel, Marie-Annick
    Newby, David E.
    Dweck, Marc R.
    JACC-CARDIOVASCULAR IMAGING, 2019, 12 (02) : 283 - 296
  • [44] Endpoint design for future renal denervation trials - Novel implications for a new definition of treatment response to renal denervation
    Lambert, Thomas
    Nahler, Alexander
    Rohla, Miklos
    Reiter, Christian
    Grund, Michael
    Kammler, Juergen
    Blessberger, Hermann
    Kypta, Alexander
    Kellermair, Joerg
    Schwarz, Stefan
    Starnawski, Jennifer A.
    Lichtenauer, Michael
    Weiss, Thomas W.
    Huber, Kurt
    Steinwender, Clemens
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 273 - 278
  • [45] Effects of renal denervation on the kidney: albuminuria, proteinuria, and renal function
    Yamazaki, Daisuke
    Konishi, Yoshio
    Kitada, Kento
    HYPERTENSION RESEARCH, 2024, 47 (10) : 2659 - 2664
  • [46] MicroRNA21 promotes interstitial fibrosis via targeting DDAH1: a potential role in renal fibrosis
    Liu, Xiu-Juan
    Hong, Quan
    Wang, Zhen
    Yu, Yan-yan
    Zou, Xin
    Xu, Li-hong
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2016, 411 (1-2) : 181 - 189
  • [48] Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure
    Boehm, Michael
    Ewen, Sebastian
    Linz, Dominik
    Reil, Jan-C.
    Schirmer, Stephan H.
    Ukena, Christian
    Mahfoud, Felix
    EUROINTERVENTION, 2013, 9 : R122 - R126
  • [49] Urinary Vitamin D Binding Protein: A Potential Novel Marker of Renal Interstitial Inflammation and Fibrosis
    Mirkovic, Katarina
    Doorenbos, Carolina R. C.
    Dam, Wendy A.
    Heerspink, Hiddo J. Lambers
    Slagman, Maartje C. J.
    Nauta, Ferdau L.
    Kramer, Andrea B.
    Gansevoort, Ronald T.
    van den Born, Jacob
    Navis, Gerjan
    de Borst, Martin H.
    PLOS ONE, 2013, 8 (02):
  • [50] The Value of T1 Mapping Techniques in the Assessment of Myocardial Interstitial Fibrosis
    Andrade Gomes, Helder Jorge
    Vieira Alves, Vinicius de Padua
    Nacif, Marcelo Souto
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2019, 27 (03) : 563 - +